Plus Therapeutics logo
Plus Therapeutics PSTV
€ 1.03 8.08%

Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024

report update icon

Plus Therapeutics Kennzahlen 2011-2024 | PSTV

Kennzahlen Jährlich Plus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.5 -0.0 -0.8 -1.3 -0.3 -0.2 -0.6 -1.2 -1.5 -1.1 -7.2 -5.7 -6.0

P/S

- - - 35.0 0.4 0.4 2.2 2.4 2.4 5.4 15.5 12.7 24.2

EPS

-4.2 -11.6 -1.1 -1.9 -8.3 -87.0 -411.6 -1.3 -2.1 -0.5 -0.4 -0.6 -0.6

EV (Enterprise Value)

11.2 M -15.4 K 4.11 M 11.3 M 7.58 M 16.2 M 23.3 M 38.5 M 39.2 M 70.5 M 212 M 196 M 198 M

EBITDA per Share

-4.04 -10.9 -1 -1.92 -1.99 -66 -300 -536 -1.11 K -2.83 K -3.34 K -3.33 K -4.39 K

EV/EBITDA

0.6 -1.1 1.2 -1.0 -0.9 -1.8 -1.5 -1.6 -6.3 -6.6 -5.5

PEG

-0.0 -0.0 0.02 -0.05 -0.0 -0.0 -0.02 -0.03 -0.02 0.05 -0.25 -0.58 3.57

P/B

-5.2 0.1 1.0 3.5 2.6 0.5 1.1 2.5 2.3 -7.1 60.2 28.6 19.4

P/CF

-0.5 -0.1 -1.1 -1.2 -0.5 -0.2 -0.7 -1.4 -1.3 -1.3 -5.4 -5.5 -5.4

ROE %

987.83 -314.58 -123.65 -271.89 -938.53 -241.80 -174.51 -200.67 -153.56 655.35 -835.79 -500.06 -326.27

ROA %

-116.93 -84.95 -60.96 -68.08 -46.87 -52.66 -71.76 -63.70 -49.72 -96.51 -62.24 -74.63 -62.97

ROCE %

988.20 -305.85 -115.28 -246.86 -41.83 -197.42 -156.68 -89.14 -78.45 -143.87 -122.81 -110.34 -77.26

Current Ratio

0.9 1.4 2.0 1.1 1.4 0.5 0.8 1.5 2.5 1.4 1.6 1.9 5.5

DSO

- - - 71.1 68.5 20.7 14.6 41.5 41.1 65.3 127.6 101.6 103.3

DIO

- - - - - 937.0 881.5 500.8 492.4 599.5 394.1 289.7 315.6

DPO

- - - 336038506.4 - 228.9 359.2 179.1 115.6 117.8 103.0 144.1 25.9

Betriebszyklus

- - - 71.1 - 957.7 896.1 542.3 533.5 664.9 521.7 391.3 419.0

Finanzkreislauf

- - - -336038435.3 - 728.7 536.9 363.2 417.9 547.0 418.8 247.2 393.1

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Plus Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.37 -0.45 -0.75 - -1 -0.59 -2.07 - -2.85 -3.56 -0.19 - -0.28 -0.25 -0.33 - -0.39 -0.45 -0.28 - -0.03 -20.67 -8.92 - -27.63 -29.67 -36.63 -0.2 -1.39 -1.94 -0.33 -0.24 -0.26 -0.43 -0.41 -0.25 0.15 0.48 -3.19 -0.08 -0.12 -0.15 -0.14 -0.14 -0.08 -0.05 -0.11 -0.06 -0.19 -0.13 -0.16 -0.13 -0.15 -0.1 -0.23

EBITDA per Share

- - -0.73 - - - -1.97 - -2.53 -3.45 -0.18 - -0.24 -0.21 -0.29 - -0.26 -0.53 -0.6 - 4.18 -3.03 -4.88 - -4.37 -7.06 -19.7 - -0.79 -1.45 -0.29 - -0.2 -0.38 -0.37 - 0.27 0.68 -2.94 - -0.09 -0.13 -0.13 - -0.11 -0.08 -0.1 - -0.16 -0.11 -0.14 - -0.13 -0.08 -0.2

ROE %

38.75 -139.56 -233.79 -358.00 -403.76 -326.76 -325.66 -128.45 -153.69 -133.16 -102.03 -77.27 -134.28 -166.05 -203.29 -153.55 -108.20 -5.85 -733.71 -1014.74 -1059.33 -1149.27 -430.77 -199.00 -231.97 -224.36 -200.86 -174.51 -186.30 -198.34 -210.11 -200.67 -178.49 -117.03 -22.28 -153.56 -30.06 122.08 293.07 655.35 233.83 -98.65 -408.60 -835.79 -574.42 -580.80 -600.40 -500.06 -510.27 -419.82 -349.36 -326.27 -83.80 -51.66 -121.38

ROA %

-149.67 -132.72 -116.94 -65.41 -88.00 -86.34 -100.74 -64.21 -79.26 -71.71 -60.32 -40.86 -55.14 -54.36 -56.12 -38.45 -36.18 -19.64 -43.83 -50.67 -60.39 -72.36 -48.24 -43.34 -56.90 -62.39 -66.27 -71.76 -72.41 -72.76 -72.14 -63.70 -56.80 -37.21 -6.90 -49.72 -57.27 -85.55 -127.90 -96.51 -105.52 -93.78 -70.87 -62.24 -47.20 -60.71 -71.30 -74.63 -79.20 -69.36 -61.11 -62.97 -16.17 -9.97 -23.43

ROCE %

66.12 -131.29 -235.75 -356.42 -401.09 -321.77 -318.69 -124.38 -148.09 -127.14 -95.80 -71.33 -117.39 -139.73 -195.77 -204.19 26.84 303.94 212.66 -124.57 -167.19 -440.85 -307.30 -132.88 -166.29 -157.07 -164.67 -131.18 -174.84 -185.10 -198.82 -146.71 -130.35 -70.33 33.78 -108.21 30.16 152.18 292.11 493.20 223.05 -185.47 -576.02 -688.41 -848.47 -738.39 -643.05 -397.47 -476.13 -394.72 -330.86 -235.65 -78.65 -43.96 -113.04

Current Ratio

0.6 0.6 0.5 0.9 1.2 1.2 1.2 1.4 2.0 1.8 2.5 2.0 2.5 2.3 2.0 1.3 1.3 1.3 1.3 1.1 1.1 1.1 1.1 1.3 1.3 1.3 1.3 1.7 1.7 1.7 1.7 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 0.9 0.9 0.9 0.9 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.2

DSO

- - - - - - - - - - - - - - - - - - - - - - 87.4 - 18.9 32.1 26.0 18.9 28.3 13.7 107.1 77.3 155.0 100.7 78.5 61.7 125.3 59.5 116.1 45.9 219.0 121.3 238.8 140.0 234.4 269.1 264.8 90.3 272.6 184.0 190.6 99.3 96.6 85.5 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - - - - - - - - - - - - - - - 87.4 - 18.9 32.1 26.0 18.9 28.3 13.7 107.1 77.3 155.0 100.7 78.5 61.7 125.3 59.5 116.1 45.9 219.0 121.3 238.8 140.0 234.4 269.1 264.8 90.3 272.6 184.0 190.6 99.3 96.6 85.5 -

Finanzkreislauf

- - - - - - - - - - - - - - - - - - - - - - 87.4 - 18.9 32.1 26.0 18.9 28.3 13.7 107.1 77.3 155.0 100.7 78.5 61.7 125.3 59.5 116.1 45.9 219.0 121.3 238.8 140.0 234.4 269.1 264.8 90.3 272.6 184.0 190.6 99.3 96.6 85.5 -

Alle Zahlen in USD-Währung